HIF1A and ovarian cancer: Inhibition of p38α activity by the specific inhibitor SB202190 impairs the expression of genes sustaining the altered metabolism of ovarian cancer cell lines and induces a shift from HIF1α- to FoxO3A-dependent transcription (Figure 1) [70].